REscue of Nephrons With ALe.F02 (RENAL-F02)
Condition: Glomerulonephritis Rapidly Progressive Interventions: Biological: ALE.F02; Drug: Rituximab; Drug: GlucoCorticoid; Drug: Cyclophosphamid; Drug: Placebo; Drug: Immunosuppressive Agents Sponsor: Alentis Therapeutics AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials